Charcot Marie Tooth disease (CMT): genetic classification
Evidence-based neurology checklist on charcot marie tooth disease (cmt): genetic classification: CMT1: Autosomal dominant demyelinating CMT1A: PMP22 gene duplication on chromosome 17 CMT1B: Myelin protein zero (MPZ) gene mutations on chromosome 1 CMT1: LITAF/SIMPLE gene mutations Chromosome 16…
CMT1: Autosomal dominant demyelinating
- CMT1A: PMP22 gene duplication on chromosome 17
- CMT1B: Myelin protein zero (MPZ) gene mutations on chromosome 1
- CMT1: LITAF/SIMPLE gene mutations Chromosome 16
- CMT1D: EGR2 gene mutations on chromosome 10q
- CMT1E: PMP22 gene mutations on chromosome 17
- CMT1F: NEFL gene mutations on chromosome 8p
- CMT1G: PMP22 gene mutations on chromosome 8q
- Fubilin-associated CMT: FBLN5 gene mutations
CMT2: Autosomal dominant axonal
CMT2B1 and CMT2B2: Autosomal recessive axonal
CMT3 (autosomal dominant or recessive)
CMT4: Autosomal recessive demyelinating
CMT5 and CMT6
CMTX: X-linked
CMTDI: Autosomal dominant intermediate
CMTRI: Autosomal recessive intermediate
Other reported CMT genes
References
- Patzko A, Shy ME. Charcot-Marie-Tooth disease and related genetic neuropathies. Continuum (Minneap Minn) 2012; 18:39-59.
- Nicolau P, Christodoulou K. Advances in the molecular diagnosis of Charcot-Marie-Tooth disease. World J Neurol 2013; 3:42-55.
- Reilly MM, Shy ME. Diagnosis and new treatments in genetic neuropathies. JNNP 2009; 80:1304–1314.
- Gonzaga-Jauregui C, Harel T, Gambin T, et al. Exome sequence analysis suggests that genetic burden contributes to phenotypic variability and complex neuropathy. Cell Rep 2015; 12:1169-1183.
- Kazamel M, Lopez MA, Bebin M, et al. Fibulin-5 mutation featuring Charcot-Marie-Tooth disease, joint hyperlaxity, and scoliosis. Neurol Genet 2020; 6(4):e476.
- And 3 more. Subscribe to see the full list